New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 1, 2024 - Samsung Bioepis and Sandoz announced the FDA approval of Pyzchiva (ustekinumab-ttwe), biosimilar to Janssen’s Stelara® (ustekinumab)./p>
Download PDF
Return to publications
